Exforge HCT Description

Active substances: Amlodipine besylate, Valsartan, Hydrochlorothiazide.
5/160/12.5 mg: White film-coated tablet, ovaloid, biconvex with beveled edge with debossing "NVR" on one side and "VCL" on the other side.
5 mg of amlodipine (as amlodipine besylate), 160 mg of valsartan and 12.5 mg hydrochlorothiazide.
10/160/12.5 mg: Pale yellow film-coated tablet, ovaloid, biconvex with beveled edge with debossing "NVR" on one side and "VDL" on the other side.
10 mg of amlodipine (as amlodipine besylate), 160 mg of valsartan and 12.5 mg hydrochlorothiazide.
10/160/25 mg: Brown-yellow film-coated tablet, ovaloid, biconvex with beveled edge with debossing "NVR" on one side and "VHL" on the other side.
10 mg of amlodipine (as amlodipine besylate) and 160 mg of valsartan and 25 mg hydrochlorothiazide.
Exforge HCT FCT are non-divisible and cannot be divided into equal doses.
Excipients/Inactive Ingredients: 5/160/12.5 mg: Microcrystalline cellulose; crospovidone; colloidal anhydrous silica; magnesium stearate; hypromellose, macrogol 4000, talc, titanium dioxide (E171).
10/160/12.5 mg: Microcrystalline cellulose; crospovidone; colloidal anhydrous silica; magnesium stearate; hypromellose, macrogol 4000, talc, titanium dioxide (E171), yellow iron oxide (E172), red iron oxide (E172).
10/160/25 mg: Microcrystalline cellulose; crospovidone; colloidal anhydrous silica; magnesium stearate; hypromellose, macrogol 4000, talc, yellow iron oxide (E172).